Privacy Interests in Prescription Data, Part 2: Patient Privacy

Authors:
Pei-Dong Dai;Tian-Yu Zhang;Zheng-Min Wang;Jim X. Chen;Ke-Qiang Wang
Affiliations:
Eye and ENT Hospital, Fudan University, China;Eye and ENT Hospital, Fudan University, China;Eye and ENT Hospital, Fudan University, China;George Mason University;Zhongshan Hospital, Fudan University, China
Venue:
Computing in Science and Engineering
Year:
2009

Citing 1
Cited 2

Virtual temporal bone dissection: a case study

Proceedings of the conference on Visualization '01

A Contour Map of the Ear's Vestibular Apparatus Based on 3D Reconstruction

Computing in Science and Engineering
A method for evaluating marketer re-identification risk

Proceedings of the 2010 EDBT/ICDT Workshops

Quantified Score

Hi-index	0.00

Visualization

Abstract

Prescription data disclosed by pharmacies without patient consent, could constitute a breach of privacy if individual patients can be re-identified by third parties. This article analyzes the concept of identifiability under Canadian and US privacy laws, including applicable thresholds of risk and the perspective from which the risk must be examined. The article goes on to examine concrete examples of how the risk of re-identifiability of prescription data can materialize in practice.